Display options
Cite
Vrinten C, van Jaarsveld CH, Waller J, et al. The structure and demographic correlates of cancer fear. BMC Cancer. 2014;14:597doi: 10.1186/1471-2407-14-597.
Vrinten, C., van Jaarsveld, C. H., Waller, J., von Wagner, C., & Wardle, J. (2014). The structure and demographic correlates of cancer fear. BMC cancer, 14597. https://doi.org/10.1186/1471-2407-14-597
Vrinten, Charlotte, et al. "The structure and demographic correlates of cancer fear." BMC cancer vol. 14 (2014): 597. doi: https://doi.org/10.1186/1471-2407-14-597
Vrinten C, van Jaarsveld CH, Waller J, von Wagner C, Wardle J. The structure and demographic correlates of cancer fear. BMC Cancer. 2014 Aug 16;14:597. doi: 10.1186/1471-2407-14-597. PMID: 25129323; PMCID: PMC4148526.
Copy Download .nbib Format: NLM
Share it on

BMC Cancer. 2014 Aug 16;14:597. doi: 10.1186/1471-2407-14-597.

The structure and demographic correlates of cancer fear.

BMC cancer

Charlotte Vrinten, Cornelia H M van Jaarsveld, Jo Waller, Christian von Wagner, Jane Wardle

Affiliations

  1. Department of Epidemiology and Public Health, Cancer Research UK Health Behaviour Research Centre, UCL, Gower Street, London WC1E 6BT, UK. [email protected].

PMID: 25129323 PMCID: PMC4148526 DOI: 10.1186/1471-2407-14-597

Abstract

BACKGROUND: Cancer is often described as the 'number one' health fear, but little is known about whether this affects quality of life by translating into high levels of worry or distress in everyday life, or which population groups are most affected. This study examined the prevalence of three components of cancer fear in a large community sample in the UK and explored associations with demographic characteristics.

METHODS: Questions on cancer fear were included in a survey mailed to a community sample of adults (n = 13,351; 55-64 years). Three items from a standard measure of cancer fear assessed: i) whether cancer was feared more than other diseases, ii) whether thinking about cancer caused discomfort, and iii) whether cancer worry was experienced frequently. Gender, marital status, education, and ethnicity were assessed with simple questions. Anxiety was assessed with the brief STAI and a standard measure of self-rated health was included.

RESULTS: Questionnaire return rate was 60% (7,971/13,351). The majority of respondents agreed or strongly agreed that they feared cancer more than other diseases (59%), and felt uncomfortable thinking about it (52%), and a quarter (25%) worried a lot about cancer. All items were significantly inter-correlated (r = .35 to .42, p's < .001), and correlated with general anxiety (r = .16 to .28, p's < .001) and self-rated health (r = -.07 to -.16, p's < .001). In multivariable analyses including anxiety and general health, all cancer fear indicators were significantly higher in women (ORs between 1.15 and 1.48), respondents with lower education (ORs between 1.40 and 1.66), and those with higher general anxiety (ORs between 1.50 and 2.11). Ethnic minority respondents (n = 285; 4.4%) reported more worry (OR: 1.85).

CONCLUSIONS: More than half of this older adult sample in the UK had cancer as greatest health fear and this was associated with feeling uncomfortable thinking about it and worrying more about it. Women and respondents with less education or from ethnic minority backgrounds were disproportionately affected by cancer fear. General anxiety and poor health were associated with cancer fear but did not explain the demographic differences.

References

  1. Soc Sci Med. 2004 Jul;59(2):249-61 - PubMed
  2. Eur J Surg Oncol. 2000 Aug;26(5):452-4 - PubMed
  3. J Behav Med. 1998 Dec;21(6):565-79 - PubMed
  4. J Behav Med. 2013 Oct;36(5):466-76 - PubMed
  5. Prev Med. 2009 Feb;48(2):189-92 - PubMed
  6. Bull Hist Med. 2007 Spring;81(1):116-38 - PubMed
  7. J Med Screen. 2008;15(3):130-6 - PubMed
  8. J Epidemiol Community Health. 1994 Feb;48(1):65-73 - PubMed
  9. Soc Sci Med. 2008 Mar;66(6):1334-45 - PubMed
  10. Psychooncology. 2006 Nov;15(11):962-8 - PubMed
  11. Prev Med. 2004 May;38(5):536-50 - PubMed
  12. Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1872-9 - PubMed
  13. BMC Public Health. 2009 Nov 24;9:431 - PubMed
  14. Prev Med. 1990 May;19(3):279-90 - PubMed
  15. J Behav Med. 2003 Apr;26(2):105-17 - PubMed
  16. Prev Med. 2006 Sep;43(3):187-90 - PubMed
  17. Prev Med. 2006 Jun;42(6):401-8 - PubMed
  18. Int J Public Health. 2010 Oct;55(5):459-68 - PubMed
  19. J Psychosoc Oncol. 2010;28(5):470-89 - PubMed
  20. J Med Screen. 2001;8(3):137-44 - PubMed
  21. J Clin Epidemiol. 1997 May;50(5):517-28 - PubMed
  22. Med Decis Making. 2008 Nov-Dec;28(6):917-25 - PubMed
  23. Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1270-5 - PubMed
  24. BMC Womens Health. 2012 Jul 26;12:21 - PubMed
  25. Urology. 2011 Apr;77(4):891-8 - PubMed
  26. J Health Commun. 2008 Jan-Feb;13(1):56-79 - PubMed
  27. Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1631-9 - PubMed
  28. Int Psychogeriatr. 2012 Jul;24(7):1163-71 - PubMed
  29. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):339-49 - PubMed
  30. BMJ. 2004 Feb 7;328(7435):301-2 - PubMed
  31. Br J Clin Psychol. 1992 Sep;31(3):301-6 - PubMed
  32. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):2980-6 - PubMed
  33. Lancet. 2010 May 8;375(9726):1624-33 - PubMed
  34. Health Psychol. 1996 Nov;15(6):430-3 - PubMed
  35. Psychooncology. 2005 Jul;14(7):517-34 - PubMed
  36. Health Expect. 2007 Dec;10(4):321-36 - PubMed
  37. J Epidemiol Community Health. 2001 Dec;55(12):895-904 - PubMed
  38. Health Educ Behav. 2008 Aug;35(4):478-93 - PubMed
  39. Prev Med. 2004 Jan;38(1):64-77 - PubMed
  40. N Engl J Med. 2014 Feb 13;370(7):595-7 - PubMed
  41. Prev Med. 2000 Oct;31(4):323-34 - PubMed
  42. Am J Public Health. 1992 Feb;82(2):249-51 - PubMed
  43. Lancet. 2002 Apr 13;359(9314):1291-300 - PubMed
  44. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):501-10 - PubMed
  45. Br J Cancer. 1998 Apr;77(8):1343-8 - PubMed
  46. Bull Cancer. 1994 Aug;81(8):683-90 - PubMed

MeSH terms

Publication Types

Grant support